MedTrace Logo

Cancer in the Elderly: Prevalence and Impact of Age Related Problems

NCT01742442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 307

Last updated 2018-04-19

No results posted yet for this study

Summary

About 50% of cancer patients are \>70 years at diagnosis. Age related somatic and psychiatric problems may influence the course of cancer and its treatment. The present study is a prospective observational study. Age related problems will be assessed by clinical frailty indicators covering areas that are recommended in geriatric oncology. The aim is to describe the frequency of age related problems in a cohort of Norwegian cancer patients \> 70 years of age, to investigate the predictive/prognostic impact of these indicators on cancer and treatment related morbidity and mortality, and to investigate the association between clinical frailty indicators, sarcopenia (severe loss of muscle mass) and inflammatory response. Patients are recruited at outpatient cancer services, Innlandet Hospital HF (SI), Oslo University Hospital, and Akershus University Hospital. Estimated sample size is 300 with 30 months inclusion and 2 years follow-up. The study emerges from SI in collaboration with several external national and international centres

Conditions

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • Diakonhjemmet Hospital

    collaborator OTHER

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • Sykehuset Innlandet HF

    lead OTHER

Principal Investigators

  • Marit S Jordhøy, MD, PhD · Sykehuset Innlandet and Oslo University Hospital

  • Siri Kristjansson, MD, PhD · Diakonhjemmet Hospital

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-04-30
Completion
2017-04-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01742442 on ClinicalTrials.gov